A detailed history of Finer Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Finer Wealth Management, Inc. holds 27,666 shares of BMY stock, worth $1.54 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
27,666
Previous 41,795 33.81%
Holding current value
$1.54 Million
Previous $2.27 Million 49.34%
% of portfolio
0.74%
Previous 1.49%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $568,692 - $748,695
-14,129 Reduced 33.81%
27,666 $1.15 Million
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $271,566 - $307,904
-5,660 Reduced 11.93%
41,795 $2.27 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $402,335 - $480,097
-8,299 Reduced 14.89%
47,455 $2.43 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $153,350 - $171,469
2,649 Added 4.99%
55,754 $3.24 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $67,978 - $75,479
1,067 Added 2.05%
53,105 $3.4 Million
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $239,250 - $271,363
3,641 Added 7.52%
52,038 $3.61 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $11,641 - $13,785
170 Added 0.35%
48,397 $3.48 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $34 - $20,439
-266 Reduced 0.55%
48,227 $3.43 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $13,144 - $14,476
-181 Reduced 0.37%
48,493 $3.73 Million
Q1 2022

Jun 06, 2022

BUY
$61.48 - $73.72 $85,149 - $102,102
1,385 Added 2.93%
48,674 $3.56 Million
Q4 2021

Jun 01, 2022

BUY
$53.63 - $62.52 $2.54 Million - $2.96 Million
47,289 New
47,289 $2.95 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Finer Wealth Management, Inc. Portfolio

Follow Finer Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finer Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Finer Wealth Management, Inc. with notifications on news.